P rogressive multifocal leukoencephalopathy (PML) is a severe, demyelinating disease of the central nervous system caused by reactivation of the JC virus, a polyomavirus. The course of the disease is usually subacute, characterized by altered mental status, motor deficits, ataxia, and visual symptoms. Before becoming a major opportunistic infection in acquired immune deficiency syndrome, the disease was seen in patients with hematologic or other malignancies, those on chronic immunosuppression, or those with longstanding inflammatory disorders. The recent introduction of natalizumab for treatment of multiple sclerosis renewed interest in non-human immunodeficiency virus (HIV)-related PML infections; however, these still represent only a small minority of PML cases. It is often fatal and although numerous therapies have been tried, there is no clear treatment shown to be of benefit, other than institution of highly active antiretroviral therapy in HIV patients and cessation of immune suppressive therapies. 1 
CASE REPORT
We describe a patient who presented to the emergency department as an urgent referral from her neuroophthalmologist with presumed cortical blindness. One month prior, the patient had complained to her husband of "dizziness" followed several days later by "blurry vision." Her symptoms slowly worsened to include vague difficulties with her peripheral vision and difficulty in reading. Ophthalmologic evaluation was inconclusive. The patient's husband described other symptoms, including progressive difficulties with operating kitchen appliances. Her medical history was significant for emphysema, hypertension, and hyperlipidemia. Her medications included aspirin, atorvastatin, verapamil, hydrochlorothiazide, tolterodine, fluticasone/salmeterol, montelukast, and albuterol as needed.
On initial physical examination in the emergency department her blood pressure was 130/59 mm Hg, pulse = 96 beats/min, and temperature 96.21F. She was oriented only to person, place, and day, had impaired recall and attention, and had difficulty following complex commands. Her mini-mental status exam was 24/30. Extraocular movements were normal. Visual field testing showed her to have constricted fields bilaterally, although the examination was complicated by her poor attention. Acuity was 20/70 bilaterally. Strength and sensation testing were intact.
Routine blood chemistry and blood count testing were unrevealing. Head computed tomography (CT) scan performed in the emergency department showed multiple areas of hypodensity in the white matter bilaterally. Also, a routine chest x-ray performed in the emergency department showed elevated hila bilaterally, bullous changes in the middle and upper zones, also extending into the lower zones as well. Apical wall loss with fibrosis was also seen. The patient was admitted to the neurology service for further workup of her mental status change.
Magnetic resonance imaging of the head with and without gadolinium showed nonspecific scattered areas of high T2/fluid attenuated inversion recovery (FLAIR) signal predominantly in the left parietooccipital and right temporal lobes without abnormal contrast enhancement. These findings were thought to be most characteristic of acute disseminated encephalomyelitis or low-grade glioma ( Fig. 1 ).
Cerebrospinal fluid (CSF) analysis showed glucose level of 73 mg/dL, protein 30 mg/dL, and white blood cells 1/mL. CSF Lyme, syphilis, and herpes zoster assays, culture, and immunoglobulin G were all negative or normal. These findings were thought to be not clearly consistent with acute disseminated encephalomyelitis. Further serum studies, including antinuclear antibody, angiotensin-converting enzyme, antineutrophil cytoplasmic antibody, and C-reactive protein were all within normal limits. A paraneoplastic panel was negative. Electroencephalography showed generalized slowing, slightly increased over the right hemisphere, without epileptiform activity.
Clinically, the patient deteriorated rapidly over the next week as further studies were obtained. She became more agitated and confused and required a 24-hour sitter. Cerebral angiography, performed to rule out cerebral vasculitis, was normal. CT of the chest, abdomen, and pelvis was obtained to evaluate for an occult malignancy. There were no findings suspicious for malignancy, however, a pretracheal lymph node, biapical scarring and pleural thinning of the lungs, and perilymphatic nodules were observed on the scan. Bronchoscopy and transbronchial biopsy were unremarkable. The pulmonary consultants therefore believed that the abnormal findings on chest x-ray and CT were likely due to long-term emphysema.
MR spectroscopy showed abnormal signal intensity within the left periatrial white matter with elevation of the choline concentration as well as a choline:creatine ratio that approached 2. This was concerning, although not specific, for neoplasm. A subsequent brain biopsy showed the presence of numerous macrophages and relative preservation of axons suggestive of a demyelinating process ( Fig. 2A) . Immunocytochemical staining of tissue sections from the biopsy specimen were positive for SV40 antigen in nuclei, which was consistent with the diagnosis of PML (Fig. 2B ). Further testing of CSF for JC virus by polymerase chain reaction assay showed 204,497 copies of the virus, further establishing the diagnosis as PML.
Because of this unexpected diagnosis, HIV testing was repeated and was normal. CD4 and CD8 counts were 182 and 122, respectively, and on repeat testing only several days later were 627 and 269. Hematologist consultation suggested the initial finding was either spurious or related to a subclinical viral infection, unrelated to the patient's current condition. They specifically commented that this was not likely representative of true CD4 lymphocytopenia.
The patient became progressively more confused and ultimately nonverbal. She was unable to eat and had several focal seizures of her right arm. After much discussion of the diagnosis and prognosis with the family, they opted for comfort care and the patient was discharged to hospice, where she expired about 1 week later.
An autopsy was obtained and showed several findings that were diagnostic for PML and, unexpectedly, systemic sarcoidosis. The heart contained dense scars in the myocardium with multinucleated giant cells (Fig. 3A ). The respiratory system showed interstitial fibrosis in the bilateral apices with multinucleated histiocytes, and giant cells present diffusely in the lung parenchyma, representing degenerated granulomas (Fig. 3B ). There was mediastinal and hilar lymphadenopathy with hyalinized lymph nodes showing multinucleated histiocytes and giant cells similar to the findings in the heart and lungs (Fig. 3C ). Neuropathologic examination showed multiple foci of rarified white matter with abundant macrophages. There were ground-glass inclusions suggestive of viral infection in numerous nuclei. There was evidence of demyelination and some degree of axonal loss (Fig. 3D ). SV40 staining was again present in multiple nuclei consistent with polyomavirus infection, as seen in the previously obtained brain biopsy. Other organ systems were essentially unremarkable.
DISCUSSION
Although there is a well-established association between PML and sarcoidosis, this is typically seen in cases where the sarcoidosis is previously known and usually has been treated. [2] [3] [4] [5] To our knowledge, there is only 1 other case report of PML as The Neurologist Volume 19, Number 1, January 2013
Progressive Multifocal Leukoencephalopathy the first clinical manifestation of sarcoidosis. In that case, however, there was inflammatory involvement of the bone marrow resulting in direct immune suppression. 5 This was not evident in our case. Although we found an initially low CD4/ CD8 count, this normalized on subsequent testing, and CD4/ CD8 lymphocytopenia can be seen in systemic sarcoidosis, independent of granulomatous involvement of the bone marrow. 6 Ultimately, we believe that this is the first reported case of PML presenting as the first clinical manifestation of sarcoidosis without clear immune suppression caused by inflammatory hematologic involvement, making it particularly noteworthy. Indeed, the unusual nature of this presentation led to multiple other diagnoses being initially considered. The association between PML and sarcoidosis was initially described in 1955 by Christenson and Fog, 7 although this was several years before PML was described as a distinct clinical entity. 2 However, coincidence of these 2 diseases is rarely seen. A literature search results in only a handful of cases where sarcoidosis is thought to be directly related to coincident PML. Völker and Kraft 4 listed only 8 published reports (a few of which listed several cases) of known sarcoidosis and PML occurring together. A recent retrospective analysis focusing on 58 HIV-negative patients with PML found that only 9% of these had underlying known systemic sarcoidosis. Importantly, studies suggest uncertainty whether inflammatory disorders such as sarcoidosis cause an intrinsic immunosuppressive risk for PML or whether prior treatment with immunosuppressive agents is necessary to confer this risk. 8 Our patient may lend evidence to the former theory.
The effectiveness of treatment for PML is uncertain in non-HIV patients. There have been numerous small trials with various experimental treatments, including cytarabine, cidofivir, topotecan, and mefloquine, all with varying results. There is no clear evidence, however, that any of these treatments are commonly effective in reversing the course of disease. 1, 3, 5, [9] [10] [11] [12] [13] These treatment options were not considered for our patient. Within about 3 weeks, the disease left her completely dependent. When the patient was unable to feed on her own, the family opted for comfort care.
The association between PML and sarcoidosis is well known, and may be independent of use of immunosuppressive medications or clear-cut hematologic involvement, as was seen in this case. Although the vast majority of PML cases occur in HIV-affected individuals, our case suggests that PML should be a diagnostic consideration in patients presenting with classic clinical and radiographic findings, despite lack of evidence of immune suppression or a chronic inflammatory condition. The delay in diagnosis likely did not affect this patient's clinical course because of the rapidity of her demise. However, in cases where experimental treatments are being considered, it is important to recognize the spectrum of patients who can be affected by this disease.
